Clinical trial

TIPS Plus Cadonilimab in Advanced HCC with Tumor Thrombosis-associated Portal Hypertension:a Prospective, Single-arm, Phase II Study

NCT05882370

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2022-12-01

PhasePHASE2

Study timeline

Study start (actual)2022-12-01Date precision: day

Registry last updated2024-10-16

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Hepatocellular Carcinomaunresolved

Interventions

CadonilimabDRUG

transjugular intrahepatic portosystemic shunt (TIPS)PROCEDURE

Sponsors & collaborators

Fei Gaolead sponsor

Mapped research locations

GuangzhouGuangdong, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05882370 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.